-
Federal
Synthetic Healthcare Database for Research (SyH-DR)
U.S. Department of Health & Human Services —
The Agency for Healthcare Research and Quality (AHRQ) created SyH-DR from eligibility and claims files for Medicare, Medicaid, and commercial insurance plans in... -
Federal
NADAC (National Average Drug Acquisition Cost) 2025
U.S. Department of Health & Human Services —
National Average Drug Acquisition Cost (NADAC) weekly reference data for the calendar year. -
Federal
NADAC (National Average Drug Acquisition Cost) 2024
U.S. Department of Health & Human Services —
National Average Drug Acquisition Cost (NADAC) weekly reference data for the calendar year. -
Federal
Pricing Comparison for Blood Disorder Treatments (Pricing as of 06/1/2025)
U.S. Department of Health & Human Services —
The Reference Document link for the downable Blood Disorder Treatment Spreadsheet can be accessed below under the Additional Information table under Related Documents. -
Federal
Pricing Comparison for Blood Disorder Treatments (Pricing as of 12/1/2024)
U.S. Department of Health & Human Services —
The Reference Document link for the downable Blood Disorder Treatment Spreadsheet can be accessed below under the Additional Information table under Related Documents. -
Federal
Pricing Comparison for Blood Disorder Treatments (Pricing as of 12/1/2023)
U.S. Department of Health & Human Services —
The Reference Document link for the downable Blood Disorder Treatment Spreadsheet can be accessed below under the Additional Information table under Related Documents. -
Federal
Pricing Comparison for Blood Disorder Treatments (Pricing as of 12/1/2021)
U.S. Department of Health & Human Services —
The Reference Document link for the downable Blood Disorder Treatment Spreadsheet can be accessed below under the Additional Information table under Related Documents. -
Federal
Product Data for Newly Reported Drugs in the Medicaid Drug Rebate Program
U.S. Department of Health & Human Services —
The Table below, updated weekly, contains newly reported, active covered outpatient drugs which were reported by participating drug manufacturers since the last... -
Federal
Exclusive Pediatric Drugs
U.S. Department of Health & Human Services —
Exclusively Pediatric (EP) designation allows for a minimum rebate percentage of 17.1 percent of Average Manufacturer Price (AMP) for single source and innovator... -
Federal
Pricing Comparison for Blood Disorder Treatments (Pricing as of 12/1/2022)
U.S. Department of Health & Human Services —
The Reference Document link for the downable Blood Disorder Treatment Spreadsheet can be accessed below under the Additional Information table under Related Documents. -
Federal
Nadac Test
U.S. Department of Health & Human Services —
NADAC (National Average Drug Acquisition Cost) 2025 -
Federal
Pricing Comparison for Blood Disorder Treatments (Pricing as of 06/1/2024)
U.S. Department of Health & Human Services —
The Reference Document link for the downable Blood Disorder Treatment Spreadsheet can be accessed below under the Additional Information table under Related Documents. -
Federal
Pricing Comparison for Blood Disorder Treatments (Pricing as of 6/1/2022)
U.S. Department of Health & Human Services —
The Reference Document link for the downable Blood Disorder Treatment Spreadsheet can be accessed below under the Additional Information table under Related Documents. -
Federal
Pricing Comparison for Blood Disorder Treatments (Pricing as of 6/1/2023)
U.S. Department of Health & Human Services —
The Reference Document link for the downable Blood Disorder Treatment Spreadsheet can be accessed below under the Additional Information table under Related Documents. -
Federal
Clotting Factor Drug Report
U.S. Department of Health & Human Services —
Clotting Factor (CF) designation allows for a minimum rebate percentage of 17.1 percent of Average Manufacturer Price (AMP) for single source and innovator multiple...